Cancer arises due to genetic aberrations that accumulate in somatic cells and alter gene expression. There are several types of genomic changes including mutations, chromosome defects, and changes to oncogenes and tumor suppressor genes. Genetic testing can identify inherited cancer risk genes and guide diagnosis and treatment, while gene therapy holds promise for directly treating cancer at the genetic level.
Audio and slides for this presentation are available on YouTube: http://youtu.be/e_KVYJX2GTs
Have you ever wondered about your genetic predisposition to cancer? How cancer evolves in families? Or how cancer cells differ from normal cells in your body? Join Judy Garber, MD, MPH, director of the Center for Cancer Genetics and Prevention at Dana-Farber Cancer Institute, as she explores the basics of cancer genetics, DNA mutations, genetic screening, management, and more.
Audio and slides for this presentation are available on YouTube: http://youtu.be/e_KVYJX2GTs
Have you ever wondered about your genetic predisposition to cancer? How cancer evolves in families? Or how cancer cells differ from normal cells in your body? Join Judy Garber, MD, MPH, director of the Center for Cancer Genetics and Prevention at Dana-Farber Cancer Institute, as she explores the basics of cancer genetics, DNA mutations, genetic screening, management, and more.
The epigenetic regulation of DNA-templated processes has been intensely studied over the last 15
years. DNA methylation, histone modification, nucleosome remodeling, and RNA-mediated targeting regulate many biological processes that are fundamental to the genesis of cancer. Here, we
present the basic principles behind these epigenetic pathways and highlight the evidence suggesting that their misregulation can culminate in cancer. This information, along with the promising clinical and preclinical results seen with epigenetic drugs against chromatin regulators, signifies that it
is time to embrace the central role of epigenetics in cancer.
Audio and slides for this presentation are also available on YouTube: http://youtu.be/ukXhuy5cXrE
Huma Q. Rana, MD, a cancer geneticist with Dana-Farber Cancer Institute, explains the cancer risk associated with BRCA1 and BRCA2 gene mutations. This presentation was originally given on July 23, 2013 as part of the "What Every Woman Should Know" event put on by Dana-Farber's Susan F. Smith Center for Women's Cancers.
The epigenetic regulation of DNA-templated processes has been intensely studied over the last 15
years. DNA methylation, histone modification, nucleosome remodeling, and RNA-mediated targeting regulate many biological processes that are fundamental to the genesis of cancer. Here, we
present the basic principles behind these epigenetic pathways and highlight the evidence suggesting that their misregulation can culminate in cancer. This information, along with the promising clinical and preclinical results seen with epigenetic drugs against chromatin regulators, signifies that it
is time to embrace the central role of epigenetics in cancer.
Audio and slides for this presentation are also available on YouTube: http://youtu.be/ukXhuy5cXrE
Huma Q. Rana, MD, a cancer geneticist with Dana-Farber Cancer Institute, explains the cancer risk associated with BRCA1 and BRCA2 gene mutations. This presentation was originally given on July 23, 2013 as part of the "What Every Woman Should Know" event put on by Dana-Farber's Susan F. Smith Center for Women's Cancers.
Introduction
Etiology of cancer
Genetic and molecular basis of cancer
The cell cycle
Pathology of cancer
Tumor origin
Tumor characteristics
Invasion and metastasis
Diagnosis and staging
Screening
Diagnosis
Staging and workup
Cancer is mainly caused by the conversion of proto-oncogenes into oncogenes. The process is known as oncogenesis.
This slide will help to get an idea about oncogenesis and also the proto-oncogenes which get converted.
The study of cancer genomes has revealed abnormalities in genes that drive the development and growth of many types of cancer. This knowledge has improved our understanding of the biology of cancer and led to new methods of diagnosing and treating the disease.
This presentation focuses on the science of Gene Therapy, the techniques of germ-line and somatic gene therapy and the mechanism of curing diseases and disorders using gene therapy. The presentation starts by discussing some common basic terms from genetics and moves on to the historical development of gene therapy techniques in chronological order. The different types of gene therapy techniques and their mechanisms have been discussed in detail subsequently. In concluding slides, some commercially available gene therapy products are mentioned and challenges of gene-therapy techniques have been highlighted.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
COVID-19 PCR tests remain a critical component of safe and responsible travel in 2024. They ensure compliance with international travel regulations, help detect and control the spread of new variants, protect vulnerable populations, and provide peace of mind. As we continue to navigate the complexities of global travel during the pandemic, PCR testing stands as a key measure to keep everyone safe and healthy. Whether you are planning a business trip, a family vacation, or an international adventure, incorporating PCR testing into your travel plans is a prudent and necessary step. Visit us at https://www.globaltravelclinics.com/
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
2. Overview
• Brief introduction
• Understand the principles of the Hallmarks of Cancer
• Discuss the types of genomic changes that occur during
cancer development
• Understand the roles of oncogenes and tumor suppressor
genes
• Identify the uses of genomics in cancer diagnosis and
treatment
• New directions- genetic testing, gene therapy
3. What is Genetics?
• Is a study of heredity.
• Genes are basic unit of heredity.
• Genes- are the fractions or part of DNA molecule
which regarded as the genetic material.
• DNA(deoxyribonucleic acid) is a double
stranded molecule that is twisted into
helix.
• Each strand has sugar phosphate back
and Bases.
• Bases- Pyrimidine and Purine.
• Pyrimidines- Cytosine “C”, Thymine “T”.
• Purines- Adenine “A”, Guanine “G”.
4. DNA has -
Nucleoside and Nucleotide
• The base-pairing rules show how
nucleotides always pair up in
DNA.
Nucleotides always pair in the same way.
-A pairs with T
- C pairs with G
• A codon is a sequence of
three nucleotides that codes
for an amino acid.
• The genetic code matches each
codon to its amino acid or
function.
5. Gene Expression
• It is a multi step process which involves
• Replication- is a process in which DNA copies itself
to produce identical daughter molecules of DNA.
• Transcription- process through which a genetic
information transfer from DNA to RNA.
• Translation – protein synthesis
6. • At the cellular level,cancer is a disease of the genome
• Cancer arises from the accumulation of genetic
aberrations in somatic cells
• These aberrations consist of mutations and chromosome
defects
• Together, they lead to altered gene expression
• Over 500 genes are now known to be involved in cancer
development.
7. Understand the principles of the
Hallmarks of Cancer
Cancer
• A disease of extraordinary diversity and complexity
• But - disparate malignancies share fundamental qualities
• The complexity merely reflects different solutions to the
same challenge:
Cancer cells must overcome multiple barriers used by
the organism to prevent expansive cell proliferation
8.
9. Genetic aberrations give rise to the
hallmarks of cancer
•If we know which genes are involved, we
can:
Have a better understanding of cancer biology
Develop diagnostic and prognostic markers
Follow the clinical course
Develop targeted treatment
10. 2. Types of genomic changes that occur
during cancer development
11.
12. Mutation
• The basic mechanism in all cancer is mutation. Mutation is change
in DNA sequence.
• Rate in humans ~5x10-9 /nucleotide / generation = 25
mutation/cell/generation
• Carcinogenic agents are involved through causing mutation. It may
be-
Germline mutations are responsible for 5% to 10% of cancer
cases. This is also called familial cancer. These mutations are
present in every cell of the body and are passed from parent to
child.
Sporadic cancer or somatic mutation are caused by tobacco,
over-exposure to UV radiation, and other toxins and chemicals.
These mutations are not in every cell of the body and are not
passed from parent to child.
13. Types of gene Mutation
I. Point mutations
II. Substitutions
III. Insertions
IV. Deletions
V. Frameshift
16. Genes & cancer
•Four classes of normal regulatory genes are
the principle target of genetic damage.
1. -The growth promoting Proto-oncogenes
2. -The growth inhibiting tumor suppressor
genes
3. -Genes that regulate programmed cell
death(Apoptosis)
4. - DNA repair genes
17. Proto-oncogene
• Have multiple roles, participating in cellular functions related
to growth & proliferation.
• Proteins encoded may function as growth factors or their
receptors, signal transducers, transcription factors or cell
cycle components.
• Mutations convert proto-oncogene into constitutively active
cellular oncogene that are involved in tumor development.
Types of Proto-oncogenes:
1)Cellular oncogenes(c- oncogenes): proto-oncogene
which have been to mutate in any individual.
2)Normal oncogene(n-oncogene): proto-oncogenes that
have not been found to mutate.
20. Oncogene
• First identified in transforming retroviruses
• Act by gain of function
• Dominant (activation of one allele sufficient)
Activated by
a) mutation
b) chromosome translocation
c) gene amplification
d) retroviral insertion
21.
22. TUMOUR SUPPRESSOR GENES
• First identified for inherited Retinoblastoma and
Wilm’sTumour
• Act by loss of function
• Recessive (inactivation of both alleles necessary)
• Inactivated by
a) mutations
b) deletions
c) DNA methylation (epigenetic)
Cause predisposition to cancer
23. Tumor suppressor genes code for proteins that slow down cell
growth and division, the loss of such proteins allows a cell to grow
and divide in an uncontrolled fashion.
26. DNA repair genes
• Each cell loses more than 10000 bases per day from
spontaneous breakdown of DNA at body temperature.
• Fortunately, the DNA repair genes code for enzymes
that fix crack in DNA.
• Genetics disorders in which DNA repair process is
defective exhibit risk for certain type of cancers-
- Xeroderma pigmentosa
- Ataxia telangiectasia.
- Bloom syndrome.
- Fanconi’s anaemia
27. • RB gene : Governor of the
cell cycle.
• p53 gene : Guardian of
genome.
28.
29.
30. Genetic testing
• Inherited cancer genes can significantly increase the
lifetime risk of developing cancer . Therefore, the
identification of well characterized germline cancer genes
can be used to predict both the type and extent of cancer
susceptibility.
• Testing is done on a small sample of body fluid or tissue—
usually blood, but sometimes saliva, cells from inside the
cheek, skin cells, or amniotic fluid.
i. A “positive test result” means that the laboratory found a
specific genetic alteration (or mutation) that is associated with a
hereditary cancer syndrome.
ii. A “negative test result” means that the laboratory did not find
the specific alteration that the test was designed to detect. this
result is most useful when working with a family in which the
specific, disease-causing genetic alteration is already known to
be present.
31. When a person has a strong family history of cancer but
the family has not been found to have a known
mutation associated with a hereditary cancer
syndrome, a negative test result is classified as an
“uninformative negative”.
If genetic testing shows a change that has not been
previously associated with cancer in other people, the
person’s test result may report “variant of unknown
significance,” or VUS.
If the test reveals a genetic change that is common in
the general population among people without cancer,
the change is called a polymorphism.
32.
33.
34. Gene therapy
The basic concept of gene therapy is to introduce a gene
with the capacity to cure or prevent the progression of a
disease.
Three different gene therapy treatment approaches:
1) Immunotherapy uses genetically modified cells and viral particles to
stimulate the immune system to destroy cancer cells.
2) Oncolytic virotherapy, which uses viral particles that replicate
within the cancer cell to cause cell death, is an emerging treatment
modality that shows great promise, particularly with metastatic cancers.
3) Gene transfer is a new treatment modality that introduces new
genes into a cancerous cell or the surrounding tissue to cause cell
death or slow the growth of the cancer.
38. No genetic disorders have been
conclusively cured by gene therapy, but
some promising results are obtained from
ongoing clinical trials.
39. Cancer is a genetic disorder in which the normal control
of cell growth is lost.
The basic mechanism in all cancer is mutation, either in
the germ line or much more frequently, in somatic cells.
Cancer is multi-factorial diseases, much remains to be
learned about the genetic processes of carcinogenesis
and about the environmental factors that alter DNA and
thus lead to malignancy.
Conclusion